COLL
NASDAQ · Pharmaceuticals
Collegium Pharmaceutical Inc
$33.25
+0.02 (+0.06%)
Open$33.48
Previous Close$33.23
Day High$33.76
Day Low$33.20
52W High$50.79
52W Low$23.23
Volume—
Avg Volume587.5K
Market Cap1.13B
P/E Ratio17.90
EPS$1.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+44.8% upside
Current
$33.25
$33.25
Target
$48.15
$48.15
$33.48
$48.15 avg
$61.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 624.29M | 524.88M | 486.77M |
| Net Income | 50.28M | 38.05M | 68.71M |
| Profit Margin | 8.1% | 7.7% | 14.1% |
| EBITDA | 134.22M | 107.21M | 134.63M |
| Free Cash Flow | — | — | 97.48M |
| Rev Growth | +18.9% | +18.9% | +18.7% |
| Debt/Equity | 2.68 | 2.68 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |